Latest filing published 13 Aug 2026 for Merck & Co., Inc., €1.2M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Chirfi Guindo discloses dealings in Merck & Co., Inc. to SEC (Form 4). Over a trading history stretching from 6 August 2026 to 13 August 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 13 August 2026, reports a transaction of €1.2M in Merck & Co., Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations